← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2010Last known activity
Feb 10, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT04314258Lead sponsorN/AFeb 10, 2020
- NCT04314258Study chairN/AFeb 10, 2020
- NCT04314258Study directorN/AFeb 10, 2020
- NCT04314258Overall official - principal investigatorN/AFeb 10, 2020
- NCT04314258Reponsible party - principal investigatorN/AFeb 10, 2020
- NCT01248143CollaboratorPhase 2/Phase 3Nov 1, 2010
Details
- Last known activity
- Feb 10, 2020